Adoptive Immunotherapy beyond CAR T-Cells

Adoptive Immunotherapy beyond CAR T-Cells

Adoptive cell immunotherapy (ACT) is a vibrant field of cancer treatment that began progressive development in the 1980s. One of the most prominent and promising examples is chimeric antigen receptor (CAR) T-cell immunotherapy for the treatment of B-cell hematologic malignancies. Despite success in...

Full description

Bibliographic Details
Main Authors: Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, Aygul Valiullina, Alexey Petukhov, Aygul Rakhmatullina, Regina Miftakhova, Michael Fainshtein, Albert Rizvanov, Emil Bulatov
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
chimeric antigen receptor
CAR T-cell
CAR NK-cell
transgeneic TCR
TIL
neoantigen
Online Access:https://www.mdpi.com/2072-6694/13/4/743

Internet

https://www.mdpi.com/2072-6694/13/4/743

Similar Items